Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 437639, 5 pages
http://dx.doi.org/10.1155/2012/437639
Research Article

The Impact of Caesarean Delivery on Paracetamol and Ketorolac Pharmacokinetics: A Paired Analysis

1Center for Clinical Pharmacology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
2Obstetrics and Gynaecology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
3Neonatal Intensive Care Unit, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium

Received 9 February 2012; Revised 20 March 2012; Accepted 21 March 2012

Academic Editor: Ali Khraibi

Copyright © 2012 Aida Kulo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. N. Feghali and D. R. Mattison, “Clinical therapeutics during pregnancy,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 783528, 13 pages, 2011. View at Publisher · View at Google Scholar
  2. G. D. Anderson, “Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach,” Clinical Pharmacokinetics, vol. 44, no. 10, pp. 989–1008, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Pilari, C. Preuße, and W. Huisinga, “Gestational influences on the pharmacokinetics of gestagenic drugs: a combined in silico, in vitro and in vivo analysis,” European Journal of Pharmaceutical Sciences, vol. 42, no. 4, pp. 318–331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Zajicek and G. P. Giacoia, “Obstetric clinical pharmacology: coming of age,” Clinical Pharmacology and Therapeutics, vol. 81, no. 4, pp. 481–482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. N. J. McDonnell, M. L. Keating, N. A. Muchatuta, T. J. G. Pavy, and M. J. Paech, “Analgesia after caesarean delivery,” Anaesthesia and Intensive Care, vol. 37, no. 4, pp. 539–551, 2009. View at Google Scholar · View at Scopus
  6. A. Kulo, M. van de Velde, J. de Hoon et al., “Pharmacokinetics of a loading dose of intravenous paracetamol post caesarean delivery,” International Journal of Obstetric Anaesthesia, vol. 21, no. 2, pp. 125–128, 2012. View at Google Scholar
  7. K. Allegaert, B. J. Anderson, G. Naulaers et al., “Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates,” European Journal of Clinical Pharmacology, vol. 60, no. 3, pp. 191–197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Wang, R. M. Dsida, and M. J. Avram, “Determination of ketorolac in human plasma by reversed-phase high-performance liquid chromatography using solid-phase extraction and ultraviolet detection,” Journal of Chromatography B, vol. 755, no. 1-2, pp. 383–386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Gregoire, L. Hovsepian, V. Gualano, E. Evene, G. Dufour, and A. Gendron, “Safety and pharmacokinetics of paracetamol following intravenous administration of 5 g during the first 24 h with a 2-g starting dose,” Clinical Pharmacology and Therapeutics, vol. 81, no. 3, pp. 401–405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Lucker, R. Bullingham, L. Hooftman, J. Lloyd, and E. Mroszczak, “Tolerability, central effects and pharmacokinetics of intravenous ketorolac tromethamine in volunteers,” International Journal of Clinical Pharmacology and Therapeutics, vol. 32, no. 8, pp. 409–414, 1994. View at Google Scholar · View at Scopus
  11. J. S. Jahr and V. K. Lee, “Intravenous acetaminophen,” Anesthesiology Clinics, vol. 28, no. 4, pp. 619–645, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. O. Miners, R. A. Robson, and D. J. Birkett, “Paracetamol metabolism in pregnancy,” British Journal of Clinical Pharmacology, vol. 22, no. 3, pp. 359–362, 1986. View at Google Scholar · View at Scopus
  13. D. R. Brocks and F. Jamali, “Clinical pharmacokinetics of ketorolac tromethamine,” Clinical Pharmacokinetics, vol. 23, no. 6, pp. 415–427, 1992. View at Google Scholar · View at Scopus
  14. K. M. Knights, L. K. Winner, D. J. Elliot, K. Bowalgaha, and J. O. Miners, “Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs,” British Journal of Clinical Pharmacology, vol. 68, no. 3, pp. 402–412, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Jamali and C. M. Kunz-Dober, “Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery,” British Journal of Clinical Pharmacology, vol. 47, no. 4, pp. 391–396, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Khalil and S. S. Läer, “Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 907461, 13 pages, 2011. View at Publisher · View at Google Scholar
  17. K. Allegaert, A. Smits, and J. van den Anker, “Physiologically-based pharmacokinetic modeling in pediatric drug development: a clinician’s request for a more integrated approach,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 103763, 3 pages, 2012. View at Publisher · View at Google Scholar